BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 27984338)

  • 1. Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update.
    Liu X; Gu W; Li Z; Lei H; Li G; Huang W
    J Hypertens; 2017 Mar; 35(3):637-644. PubMed ID: 27984338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the treatment and control of hypertension in urban and rural residents of the northeastern region of the People's Republic of China: a cross-sectional study.
    Zhao L; Sun W; Wang J; Wu J; Zhang Y; Liu Y; Liu B
    Clin Exp Hypertens; 2019; 41(4):366-372. PubMed ID: 29939765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People's Republic of China: A cross-sectional study.
    Wang J; Sun W; Wells GA; Li Z; Li T; Wu J; Zhang Y; Liu Y; Li L; Yu Y; Liu Y; Qi C; Lu Y; Liu N; Yan Y; Liu L; Hui G; Liu B
    PLoS One; 2018; 13(4):e0195340. PubMed ID: 29621328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden and correlates of hypertension among Chinese rural population in Han, Uygur, and Kazak: a cross-sectional study.
    Wang YT; Adi D; Yu ZX; Ma YT; Yang YN; Li XM; Ma X; Liu F; Chen BD
    J Am Soc Hypertens; 2017 Nov; 11(11):737-745.e3. PubMed ID: 29031803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on effects of community-based management of hypertension patients aged ≥35 years and influencing factors in urban and rural areas of China, 2010].
    Zeng XY; Zhang M; Li YC; Huang ZJ; Wang LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):612-7. PubMed ID: 27188348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study.
    Chen L; Zong Y; Wei T; Sheng X; Shen W; Li J; Niu Z; Zhou H; Zhang Y; Yuan Y; Chen Q; Zhong H
    BMC Public Health; 2015 Apr; 15():383. PubMed ID: 25886600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study.
    Dastan I; Erem A; Cetinkaya V
    Clin Exp Hypertens; 2018; 40(1):90-98. PubMed ID: 28686064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension in the adult Congolese population of Southern Kivu: Results of the Vitaraa Study].
    Katchunga PB; M'buyamba-Kayamba JR; Masumbuko BE; Lemogoum D; Kashongwe ZM; Degaute JP; Kabinda JM; M'Buyamba-Kabangu JR
    Presse Med; 2011 Jun; 40(6):e315-23. PubMed ID: 21376507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012.
    Sengul S; Akpolat T; Erdem Y; Derici U; Arici M; Sindel S; Karatan O; Turgan C; Hasanoglu E; Caglar S; Erturk S;
    J Hypertens; 2016 Jun; 34(6):1208-17. PubMed ID: 26991534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China.
    Wei Q; Sun J; Huang J; Zhou HY; Ding YM; Tao YC; He SM; Liu YL; Niu JQ
    J Hum Hypertens; 2015 Jan; 29(1):64-8. PubMed ID: 24990419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, awareness, treatment and control of hypertension among adults in rural north-western China: a cross-sectional population survey.
    Dong C; Ge P; Ren X; Fan H; Yan X
    J Int Med Res; 2013 Aug; 41(4):1291-300. PubMed ID: 23816929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for prehypertension and hypertension among adults in Central China from 2000-2011.
    Chen C; Yuan Z
    Clin Exp Hypertens; 2018; 40(8):734-743. PubMed ID: 29513624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, awareness, treatment, and control of hypertension in rural adults from Liaoning Province, northeast China.
    Dong G; Sun Z; Zheng L; Li J; Zhang X; Zhang X; Xu C; Li J; Hu D; Sun Y
    Hypertens Res; 2007 Oct; 30(10):951-8. PubMed ID: 18049027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China.
    Li W; Gu H; Teo KK; Bo J; Wang Y; Yang J; Wang X; Zhang H; Sun Y; Jia X; He X; Zhao X; Cheng X; Li J; Rangarajan S; Chen C; Yusuf S; Liu L;
    J Hypertens; 2016 Jan; 34(1):39-46. PubMed ID: 26630211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence, low awareness, treatment and control rates of hypertension in Guinea: results from a population-based STEPS survey.
    Camara A; Baldé NM; Diakité M; Sylla D; Baldé EH; Kengne AP; Baldé MD
    J Hum Hypertens; 2016 Apr; 30(4):237-44. PubMed ID: 26310186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on risk factors and behavior features related to chronic diseases among adults in Shanghai].
    Xu JY; Li XJ; Yao HH; Yan QH; Lu W; Zhong WJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Sep; 47(9):821-5. PubMed ID: 24351563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension prevalence, awareness, treatment, and control and sodium intake in Shandong Province, China: baseline results from Shandong-Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011.
    Bi Z; Liang X; Xu A; Wang L; Shi X; Zhao W; Ma J; Guo X; Zhang X; Zhang J; Ren J; Yan L; Lu Z; Wang H; Tang J; Cai X; Dong J; Zhang J; Chu J; Engelgau M; Yang Q; Hong Y; Wang Y
    Prev Chronic Dis; 2014 May; 11():E88. PubMed ID: 24854239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension prevalence, awareness, treatment, control and associated factors in a developing southern Chinese population: analysis of serial cross-sectional health survey data 2002-2010.
    Lao XQ; Xu YJ; Wong MC; Zhang YH; Ma WJ; Xu XJ; Cai QM; Xu HF; Wei XL; Tang JL; Griffiths SM
    Am J Hypertens; 2013 Nov; 26(11):1335-45. PubMed ID: 23846723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lu J; Lu Y; Wang X; Li X; Linderman GC; Wu C; Cheng X; Mu L; Zhang H; Liu J; Su M; Zhao H; Spatz ES; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    Lancet; 2017 Dec; 390(10112):2549-2558. PubMed ID: 29102084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.